BiotechReality – Covering Industry, Business, and Academia
Explore the frontiers of Biotechnology, Pharma/Biopharma industry and Science with BiotechReality. We publish news, reports, views and articles.
Surgery to remove the tumor is the standard of care for individuals with stage III or IV clear cell renal cell carcinoma.
Editor's Desk
4 September 2024
The rates of heart failure events and cardiovascular death were lower in the finerenone group compared with the placebo group.
Editor's Desk
31 May 2024
22 patients at the University Hospital Vienna and Charité –Universitätsmedizin Berlin who were diagnosed with antibody-mediated rejection (AMR) after a kidney transplant
A SciRealityPress Associate
Contents in the website is licensed under CC BY-NC 4.0
Disclaimer: The content on this website is not meant to provide medical or any other professional advice. Understand and use the information, double check if necessary. All trademarked names mentioned in the contents belongs to their respective owners. Stock exchange data providing by Stockdio